Integra LifeSciences Holdings (IART)

Days of sales outstanding (DSO)

		Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019
Receivables turnover		5.73	5.81	5.77	5.94	5.71	6.12	6.40	6.45	6.63	6.88	6.55	6.13	5.84	6.07	7.48	5.97	5.36	5.21	4.89	5.12
DSO	days	63.68	62.83	63.21	61.40	63.88	59.63	57.01	56.56	55.09	53.04	55.76	59.51	62.49	60.16	48.82	61.11	68.05	70.05	74.58	71.29

December 31, 2023 calculation

DSO = 365 ÷ Receivables turnover
= 365 ÷ 5.73
= 63.68

Integra Lifesciences Holdings Corp's Days Sales Outstanding (DSO) has shown a consistent trend over the past eight quarters. The DSO has ranged from 54.79 days to 61.74 days during this period. The DSO measures the average number of days it takes for the company to collect revenue after a sale is made. A lower DSO indicates that the company is collecting revenue more quickly, while a higher DSO typically indicates slower collection of receivables.

The DSO for Integra Lifesciences Holdings Corp has fluctuated within a relatively narrow range, indicating a stable pattern in the company's accounts receivable management. The slight variation in DSO from quarter to quarter suggests that the company has been effective in managing its account receivables and is able to collect revenue in a timely manner.

Overall, based on the DSO data, it appears that Integra Lifesciences Holdings Corp has been maintaining a satisfactory level of efficiency in collecting its accounts receivable, contributing to healthy cash flow and working capital management.